Bryce Point Capital’s Pfizer PFE Stock Holding History

Bryce Point Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-31,144	Closed	-$805K	–	244
2025 Q1	$805K	Buy	+31,144	New	+$815K	0.61%	88

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Bryce Point Capital's PFE Position: Q2 2025 in Review

Bryce Point Capital sold out of Pfizer (PFE) in Q2 2025, closing a stake of 31,144 shares — an estimated $805K sold.

Bryce Point Capital first reported a position in PFE in Q1 2025 and held it in 1 quarter. The position peaked at $805K in Q1 2025. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

Bryce Point Capital reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
Bryce Point Capital sold 31,144 Pfizer shares in Q2 2025, an estimated $805K.
Bryce Point Capital first reported a position in Pfizer in Q1 2025 and held it in 1 quarter.
Bryce Point Capital's Pfizer position peaked at $805K in Q1 2025.
2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Bryce Point Capital's 13F filing for Q2 2025, filed 5 Aug 2025.